Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.
autoantibody
autoimmune encephalitis
connective tissue disease
depression
multiple sclerosis
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
10
2019
accepted:
16
07
2020
entrez:
14
9
2020
pubmed:
15
9
2020
medline:
15
9
2020
Statut:
epublish
Résumé
In a subgroup of patients with mood disorders, clear-cut organic disorders are responsible for depressive symptoms (e.g., autoimmune diseases such as multiple sclerosis or systemic lupus erythematosus). In these cases, an organic affective disorder can be diagnosed. The authors present the case of a 59-year-old male patient who developed a severe depressive episode over approximately 6 months and was, therefore, admitted to the hospital. In retrospect, he reported that, at age 39, he suffered from self-limiting sensory disturbances and muscle weakness in both legs. The current magnetic resonance imaging of his brain showed several conspicuous FLAIR-hyperintense supratentorial white matter lesions compatible with chronic inflammatory brain disease. Imaging of the spinal axis revealed no clear spinal lesions. Cerebrospinal fluid (CSF) analyses showed CSF-specific oligoclonal bands. Therefore, multiple sclerosis was diagnosed. Further CSF analyses, using tissue-based assays with indirect immunofluorescence on unfixed murine brain tissue, revealed a (peri-)nuclear signal and a strong neuritic signal of many neurons, especially on granule cells in the cerebellum, hippocampus, and olfactory bulb, as well as in the corpus callosum. Additionally, antinuclear antibody (ANA) titers of 1:12,800 and a lymphopenia were detected in blood tests. Further system clarification showed no suspicion of rheumatic or oncological disease. Anti-inflammatory treatment led to rapid and sustained improvement. The present patient suffered from a probable "autoimmune depression" in the context of newly diagnosed multiple sclerosis with typical MRI and CSF pathologies, alongside mild concomitant latent systemic autoimmune process (with high-titer ANAs and lymphopenia) and unknown antineuronal antibodies. The case report illustrates that a depressive syndrome suggestive of primary idiopathic depressive disorder may be associated with an autoimmune brain involvement. The detection of such organic affective disorders is of high clinical relevance for affected patients, as it enables alternative and more causal treatment approaches.
Sections du résumé
BACKGROUND
BACKGROUND
In a subgroup of patients with mood disorders, clear-cut organic disorders are responsible for depressive symptoms (e.g., autoimmune diseases such as multiple sclerosis or systemic lupus erythematosus). In these cases, an organic affective disorder can be diagnosed.
CASE PRESENTATION
METHODS
The authors present the case of a 59-year-old male patient who developed a severe depressive episode over approximately 6 months and was, therefore, admitted to the hospital. In retrospect, he reported that, at age 39, he suffered from self-limiting sensory disturbances and muscle weakness in both legs. The current magnetic resonance imaging of his brain showed several conspicuous FLAIR-hyperintense supratentorial white matter lesions compatible with chronic inflammatory brain disease. Imaging of the spinal axis revealed no clear spinal lesions. Cerebrospinal fluid (CSF) analyses showed CSF-specific oligoclonal bands. Therefore, multiple sclerosis was diagnosed. Further CSF analyses, using tissue-based assays with indirect immunofluorescence on unfixed murine brain tissue, revealed a (peri-)nuclear signal and a strong neuritic signal of many neurons, especially on granule cells in the cerebellum, hippocampus, and olfactory bulb, as well as in the corpus callosum. Additionally, antinuclear antibody (ANA) titers of 1:12,800 and a lymphopenia were detected in blood tests. Further system clarification showed no suspicion of rheumatic or oncological disease. Anti-inflammatory treatment led to rapid and sustained improvement.
CONCLUSION
CONCLUSIONS
The present patient suffered from a probable "autoimmune depression" in the context of newly diagnosed multiple sclerosis with typical MRI and CSF pathologies, alongside mild concomitant latent systemic autoimmune process (with high-titer ANAs and lymphopenia) and unknown antineuronal antibodies. The case report illustrates that a depressive syndrome suggestive of primary idiopathic depressive disorder may be associated with an autoimmune brain involvement. The detection of such organic affective disorders is of high clinical relevance for affected patients, as it enables alternative and more causal treatment approaches.
Identifiants
pubmed: 32922313
doi: 10.3389/fpsyt.2020.00745
pmc: PMC7457046
doi:
Types de publication
Case Reports
Langues
eng
Pagination
745Informations de copyright
Copyright © 2020 Endres, Rauer, Venhoff, Süß, Dersch, Runge, Fiebich, Nickel, Matysik, Maier, Domschke, Egger, Prüss and van Elst.
Références
Brain. 2016 Oct;139(Pt 10):2641-2652
pubmed: 27543972
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Nervenarzt. 2019 May;90(5):547-563
pubmed: 30968197
Nervenarzt. 2019 Jul;90(7):745-761
pubmed: 31197396
Nat Rev Neurol. 2014 Oct;10(10):579-96
pubmed: 25201240
Int Rev Psychiatry. 2017 Oct;29(5):463-472
pubmed: 28681616
Psychosomatics. 2017 May - Jun;58(3):228-244
pubmed: 28545782
N Engl J Med. 2018 Mar 1;378(9):840-851
pubmed: 29490181
Front Psychiatry. 2019 Apr 25;10:226
pubmed: 31105597
BMC Psychiatry. 2017 Feb 14;17(1):70
pubmed: 28196529
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
BMC Psychiatry. 2016 Jun 06;16:184
pubmed: 27268005
Lancet Psychiatry. 2019 Mar;6(3):235-246
pubmed: 30765329
Nat Rev Neurol. 2019 Jun;15(6):317-328
pubmed: 30988501
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
J Affect Disord. 2016 Jul 01;198:178-84
pubmed: 27017374
Front Neurol. 2019 Mar 05;10:175
pubmed: 30891000
Asian J Psychiatr. 2017 Dec;30:54-55
pubmed: 28753451